Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized, Placebo-controlled, Double-blinded Study of Single Immediate Instillation of EO9 After TURBT in Patients With NMIBC

NCT01475266 is registered in ClinicalTrials.gov with Nippon Kayaku Co., Ltd. as lead sponsor.

NCT NCT01475266
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01475266 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized, Placebo-controlled, Double-blinded Study of Single Immediate Instillation of EO9 After TURBT in Patients With NMIBC
Lead sponsor
Nippon Kayaku Co., Ltd.
Phase
Phase 2/3
Overall status
Terminated
Start date
November 30, 2011
Completion date
April 30, 2013
Enrollment
51 (actual)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

bladder cancer